ABEONA THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.93 USD | +2.19% |
|
+7.74% | +58.28% |
| Mar. 18 | Sector Update: Health Care Stocks Edge Up Late Monday Afternoon | MT |
| Mar. 18 | Sector Update: Health Care Stocks Rise Monday Afternoon | MT |
Chart calendar Abeona Therapeutics Inc.
e4bb498ce75c0f91db.sY2aC9EoNMmkCVDCSu73iOk6r9089dvx-f9OQTR9DNE.4uujcrldc7jrMAKuDq2G7KANyZV9ueqFnbALO3kcPujo4thkvx5khdQ9ZA~8d5650d9773731ed23bb20682cf7154e
Upcoming events on Abeona Therapeutics Inc.
Past events on Abeona Therapeutics Inc.
| 2024-03-18 08:30 am | Q4 2023 Earnings Call |
| 2024-03-18 07:30 am | Q4 2023 Earnings Release |
| 2023-11-13 08:30 am | Q3 2023 Earnings Call |
| 2023-11-13 07:30 am | Q3 2023 Earnings Release |
| 2023-09-27 09:30 am | Jefferies Cell & Genetic Medicine Summit |
| 2023-09-26 02:10 pm | Cantor Global Healthcare Conference |
| 2023-09-13 10:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-08 08:30 am | Q2 2023 Earnings Call |
| 2023-08-08 07:30 am | Q2 2023 Earnings Release |
| 2023-06-09 09:00 am | Jefferies Global Healthcare Conference - Fireside Chat |
| 2023-05-24 08:30 am | Business Update Call - Q1 2023 Earnings |
| 2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract Number: 1478 |
| 2023-05-18 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract Number: 1131 |
| 2023-05-17 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract Number: 715 |
| 2023-05-17 09:00 am | Annual General Meeting |
| 2023-05-11 07:30 am | Q1 2023 Earnings Release |
| 2023-05-11 12:15 am | International Societies for Investigative Dermatology Meeting - Abstract No: 806 |
| 2023-03-29 08:30 am | Q4 2022 Earnings Call |
| 2023-03-29 07:30 am | Q4 2022 Earnings Release |
| 2022-11-14 07:30 am | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 10,0 9,28 7.82% | 3,00 0,00 - | 1,41 2,32 -39.13% | 3,50 3,50 0% | 17,9 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -77,1 -79,9 3.55% | -81,4 -79,9 -1.91% | -89,8 -58,8 -52.71% | -50,9 -44,6 -14.2% | -47,1 -45,3 -4.11% | -48,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -76,3 -79,1 3.54% | -84,2 -83,2 -1.24% | -84,9 -68,3 -24.36% | -39,7 -55,3 28.22% | -54,2 -45,0 -20.33% | -52,4 |
|
Net income Million USD | Released Forecast Spread | -76,3 -78,9 3.35% | -84,2 -81,3 -3.65% | -84,9 -59,0 -44% | -43,5 -53,9 19.37% | -54,2 -47,3 -14.59% | -52,4 |
|
EPS USD | Released Forecast Spread | -37,8 -37,8 0.19% | -22,8 -20,6 -10.53% | -21,5 -13,9 -54.49% | -5,53 -3,92 -41.25% | -2,53 -2,23 -13.45% | -1,92 |
| Announcement Date | 16/03/20 | 24/03/21 | 31/03/22 | 29/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,00 0,00 - | 0,35 0,00 - | 1,00 0,00 - | 0,00 0,00 - | 0,07 1,00 -93.2% | 0,00 0,00 - | 3,50 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,50 | 0,50 | 4,80 | 12,6 |
|
EBIT Million USD | Released Forecast Spread | -46,7 -15,6 -198.41% | -20,6 -16,0 -28.69% | -8,01 -14,5 44.77% | -9,38 -10,3 8.49% | -12,9 -8,95 -44.54% | -12,0 -10,8 -11.98% | -11,6 -12,5 6.67% | -11,3 -13,2 13.81% | -13,2 -11,5 -14.86% | -14,9 | -15,8 | -12,3 | -5,65 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -46,7 -25,9 -80.59% | -20,8 -16,0 -29.94% | -8,30 -14,5 42.79% | -9,48 -10,5 9.68% | -1,13 -12,9 91.27% | -9,11 -10,8 15.68% | -16,7 -12,7 -31.48% | -11,8 -13,2 10.11% | -16,6 -11,5 -44.69% | -15,3 | -16,4 | -12,9 | -6,90 |
|
Net income Million USD | Released Forecast Spread | -46,7 -18,6 -150.71% | -20,8 -12,3 -69.72% | -12,1 -11,2 -8.31% | -9,48 -10,5 9.36% | -1,13 -12,9 91.27% | -9,11 -10,8 15.68% | -16,7 -12,7 -31.48% | -11,8 -13,2 10.11% | -16,6 -11,8 -41.05% | -15,3 | -16,4 | -12,9 | -6,90 |
|
EPS USD | Released Forecast Spread | -11,3 -3,67 -206.82% | -3,50 -2,38 -47.37% | -2,08 -0,68 -208.15% | -1,48 -1,75 15.27% | -0,75 | -0,54 -0,61 11.48% | -0,92 -0,67 -36.63% | -0,48 -0,53 10% | -0,64 -0,47 -36.17% | -0,57 | -0,61 | -0,48 | -0,25 |
| Announcement Date | 31/03/22 | 13/05/22 | 11/08/22 | 14/11/22 | 29/03/23 | 11/05/23 | 08/08/23 | 13/11/23 | 18/03/24 | - | - | - | - |
More events
Past sector events for Abeona Therapeutics Inc.
| Today | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
| 2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABEO Stock
- Calendar Abeona Therapeutics Inc.
